InvestorsHub Logo
Followers 45
Posts 6206
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Sunday, 07/16/2023 6:57:05 AM

Sunday, July 16, 2023 6:57:05 AM

Post# of 460094

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023



FYI - Copycat of B&E?

https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-presents-positive-topline-results-first
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News